title: How do we define efficacy in comparing osteoclast-targeted agents in metastatic breast cancer?
authors.forename: Julie R
authors.initials: JR
authors.lastname: Gralow
authors.forename: Allan
authors.initials: A
authors.lastname: Lipton
authors.forename: Alison T
authors.initials: AT
authors.lastname: Stopeck
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans
chemical_list: D050071:Bone Density Conservation Agents